FI104723B - Menetelmä immunoaktiivisten peptidien valmistamiseksi - Google Patents

Menetelmä immunoaktiivisten peptidien valmistamiseksi Download PDF

Info

Publication number
FI104723B
FI104723B FI915891A FI915891A FI104723B FI 104723 B FI104723 B FI 104723B FI 915891 A FI915891 A FI 915891A FI 915891 A FI915891 A FI 915891A FI 104723 B FI104723 B FI 104723B
Authority
FI
Finland
Prior art keywords
peptide
phe
lys
terminal end
gly
Prior art date
Application number
FI915891A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI915891A0 (fi
Inventor
Ian Victor Lewin
Denis Raymond Stanworth
Sarita Nayyar
Valerie Jones
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of FI915891A0 publication Critical patent/FI915891A0/fi
Application granted granted Critical
Publication of FI104723B publication Critical patent/FI104723B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI915891A 1989-06-15 1991-12-13 Menetelmä immunoaktiivisten peptidien valmistamiseksi FI104723B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8913737 1989-06-15
GB898913737A GB8913737D0 (en) 1989-06-15 1989-06-15 A novel anti-allergy treatment
PCT/GB1990/000926 WO1990015878A1 (en) 1989-06-15 1990-06-15 Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB9000926 1990-06-15

Publications (2)

Publication Number Publication Date
FI915891A0 FI915891A0 (fi) 1991-12-13
FI104723B true FI104723B (fi) 2000-03-31

Family

ID=10658467

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915891A FI104723B (fi) 1989-06-15 1991-12-13 Menetelmä immunoaktiivisten peptidien valmistamiseksi

Country Status (18)

Country Link
US (1) US5601821A (de)
EP (2) EP0477231B1 (de)
JP (2) JPH04505922A (de)
KR (1) KR0181313B1 (de)
AT (1) ATE122401T1 (de)
CA (1) CA2057860C (de)
DE (1) DE69019348T2 (de)
DK (1) DK0477231T3 (de)
ES (1) ES2073028T3 (de)
FI (1) FI104723B (de)
GB (2) GB8913737D0 (de)
IE (1) IE71677B1 (de)
NO (1) NO914937L (de)
NZ (1) NZ234085A (de)
PH (1) PH30233A (de)
PT (1) PT94381B (de)
WO (1) WO1990015878A1 (de)
ZA (1) ZA904670B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU2195395A (en) * 1994-03-28 1995-10-17 United Biomedical Inc. Synthetic peptide based immunogens for the treatment of allergy
GB9412714D0 (en) * 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
GB9416321D0 (en) * 1994-08-12 1994-10-05 Peptide Therapeutics Ltd Peptides and antibodies and their use in treatment of carcinomas
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
CA2245497C (en) * 1996-03-01 2009-02-24 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
WO1997045069A1 (en) * 1996-05-29 1997-12-04 Cell Genesys, Inc. Cationic polymer/lipid nucleic acid delivery vehicles
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
EP1195161A3 (de) 2000-08-30 2002-07-24 Pfizer Products Inc. Anti-IgE Vakzine
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
RU2191602C1 (ru) * 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
EP2338510A1 (de) 2002-07-19 2011-06-29 Novartis Pharma AG Impfstoffzusammensetzungen, die Amyloid-beta1-6 Antigen-Arrays enthalten
DK1534335T4 (en) 2002-08-14 2015-10-05 Macrogenics Inc FCGAMMARIIB-SPECIFIC ANTIBODIES AND PROCEDURES FOR USE THEREOF
ATE419008T1 (de) 2004-04-26 2009-01-15 Innate Pharma Adjuvante zusammensetzung und anwendungsverfahren dafür
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US8541559B2 (en) 2006-06-12 2013-09-24 Cytos Biotechnology Ag Process for producing aggregated oligonucleotides
ES2599319T3 (es) 2006-06-26 2017-02-01 Macrogenics, Inc. Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
EP2401300B1 (de) * 2009-02-25 2018-01-10 Academia Sinica AN MENSCHLICHE mIgE-AUF-B-LYMPHOZYTEN BINDENDE ANTI-C[epsilon]MX-ANTIKÖRPER
WO2013158274A1 (en) 2012-04-20 2013-10-24 Academia Sinica ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
JP6899890B2 (ja) * 2016-03-18 2021-07-07 ジェンクリＧｅｎｃｌｉｓ アレルギーの分子起源
WO2019085902A1 (en) 2017-10-31 2019-05-09 Fountain Biopharma Inc. Treating ige-mediated allergic diseases
JP7503857B2 (ja) * 2022-04-11 2024-06-21 緑茵生技股▲ふん▼有限公司 抗アレルギー性ペプチド及びその免疫調節と抗アレルギーに用いられる用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
DE2861593D1 (en) * 1977-06-29 1982-03-11 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
AU1484688A (en) * 1987-02-20 1988-09-14 Imclone Systems, Inc. Monoclonal antibodies in vaccine formulations
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
CA2082529A1 (en) * 1990-05-25 1991-11-26 Denis R. Stanworth Immunodiagnostic assay for rheumatoid arthritis
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0403312A1 (de) 1990-12-19
AU5814890A (en) 1991-01-08
JPH04505922A (ja) 1992-10-15
FI915891A0 (fi) 1991-12-13
GB9013478D0 (en) 1990-08-08
IE71677B1 (en) 1997-02-26
ES2073028T3 (es) 1995-08-01
US5601821A (en) 1997-02-11
NO914937L (no) 1991-12-19
GB8913737D0 (en) 1989-08-02
KR920702723A (ko) 1992-10-06
CA2057860A1 (en) 1990-12-16
ATE122401T1 (de) 1995-05-15
PT94381A (pt) 1991-02-08
NO914937D0 (no) 1991-12-13
IE902154L (en) 1990-12-15
KR0181313B1 (ko) 1999-04-01
DE69019348T2 (de) 1995-09-21
JP2000152783A (ja) 2000-06-06
EP0477231A1 (de) 1992-04-01
WO1990015878A1 (en) 1990-12-27
PT94381B (pt) 1996-11-29
DK0477231T3 (da) 1995-07-10
AU646808B2 (en) 1994-03-10
DE69019348D1 (de) 1995-06-14
ZA904670B (en) 1992-02-26
CA2057860C (en) 2000-05-09
PH30233A (en) 1997-02-05
NZ234085A (en) 1991-09-25
EP0477231B1 (de) 1995-05-10
IE902154A1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
FI104723B (fi) Menetelmä immunoaktiivisten peptidien valmistamiseksi
KR100584051B1 (ko) 알레르기에 대한 백신 접종 및 치료를 위한 펩티드임뮤노겐
SK11295A3 (en) Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
CZ20013081A3 (cs) Epitopy a mimotopy získané z oblastí C-epsilon-2 nebo C-epsilon-4 IgE, jejich antagonisté a jejich terapeutické pouľití
EP0709455A1 (de) Monoklonaler Antikörper gegen menschliches Glicentin, Hybridoma zur Herstellung dieses Antikörpers und Testverfahren für menschliches Glicentin unter Verwendung dieses Antikörpers
US5955076A (en) Immunoactive peptides and antibodies and their use in anti-allergy treatment
AU646808C (en) Immunoactive peptides and antibodies and their use in anti-allergy treatment
US20050152892A1 (en) Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics uses
US20030170229A1 (en) Vaccine
HK1014962B (en) Peptide immunogens for vaccination against and treatment of allergy

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PEPTIDE THERAPEUTICS LIMITED

GB Transfer or assigment of application

Owner name: PEPTIDE THERAPEUTICS LIMITED